sur EXASOL AG (isin : DE000A0LR9G9)
Exasol's Stable ARR Amid Challenges in Revenue Growth
Exasol AG reported stable Annual Recurring Revenue (ARR) at EUR 37.9 million in Q3 2026, nearly matching the prior year's level. Despite a decline in revenue from EUR 31.7 million to EUR 28.7 million in the first nine months, the company confirmed its 2026 guidance. New customers and a reduction in churn were positive trends, but weaker upselling with existing clients impacted overall revenue growth.
Exasol's strategy in focus industries is yielding results, with new ARR reaching EUR 26.9 million as of September 2026. Notably, a Fortune 500 pharmaceutical company became a new customer, marking a significant milestone for Exasol's agentic AI strategy. The company expects further expansion with this relationship going into 2027.
Partnership developments were also pivotal. Collaborations with adesso and MariaDB have progressed, with the commercial launch of the MariaDB Exa product. Exasol targets a revitalization of ARR momentum through enhanced data sovereignty solutions, amidst global geopolitical concerns.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EXASOL AG